These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29166741)

  • 21. High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.
    Vergez F; Green AS; Tamburini J; Sarry JE; Gaillard B; Cornillet-Lefebvre P; Pannetier M; Neyret A; Chapuis N; Ifrah N; Dreyfus F; Manenti S; Demur C; Delabesse E; Lacombe C; Mayeux P; Bouscary D; Recher C; Bardet V
    Haematologica; 2011 Dec; 96(12):1792-8. PubMed ID: 21933861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of CD25/CD123 pattern of expression in acute myeloid leukemia patients with normal cytogenetic.
    Aref S; Azmy E; Ibrahim L; Sabry M; Agdar ME
    Leuk Res Rep; 2020; 13():100203. PubMed ID: 32514390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
    Chalandon Y; Barnett MJ; Horsman DE; Conneally EA; Nantel SH; Nevill TJ; Nitta J; Shepherd JD; Sutherland HJ; Toze CL; Hogge DE
    Biol Blood Marrow Transplant; 2002; 8(8):435-43. PubMed ID: 12234169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of CD44, CD87 and CD123 in Acute Leukemia and Its Correlation with Cellular Immunity].
    Wang SW; Yao HX; Rao R; Xia MJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1794-1798. PubMed ID: 31839040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
    Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
    Bras AE; de Haas V; van Stigt A; Jongen-Lavrencic M; Beverloo HB; Te Marvelde JG; Zwaan CM; van Dongen JJM; Leusen JHW; van der Velden VHJ
    Cytometry B Clin Cytom; 2019 Mar; 96(2):134-142. PubMed ID: 30450744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes of CD34
    Zahran AM; Aly SS; Rayan A; El-Badawy O; Fattah MA; Ali AM; ElBadre HM; Hetta HF
    Oncotarget; 2018 Sep; 9(75):34056-34065. PubMed ID: 30344921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new prognostic stratification for patients with acute myeloid leukemia].
    Jiang B; Mi YC; Lin D; Cai XJ; Fu MW; Li W; Wang Y; Liu XP; Xue YP; Bian SG; Wang JX
    Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):316-20. PubMed ID: 19576124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity Assessment and Apoptosis-related Gene Profiling of Antibody Treated Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL) Cancerous Cell Lines.
    Habibi-Anbouhi M; Kafi Z; Ghazizadeh L; Kharazi S; Behdani M; Faraji F; Shokrgozar MA
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(6):679-687. PubMed ID: 32245312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between myeloperoxidase expression and gene alterations and prognosis in acute myeloid leukemia].
    Dong XY; Li YL; Jiang L; Wu CY; Shang BJ; Zhang L; Cheng W; Zhu ZM
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):40-45. PubMed ID: 30704227
    [No Abstract]   [Full Text] [Related]  

  • 32. Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.
    Han L; Jorgensen JL; Brooks C; Shi C; Zhang Q; Nogueras González GM; Cavazos A; Pan R; Mu H; Wang SA; Zhou J; Ai-Atrash G; Ciurea SO; Rettig M; DiPersio JF; Cortes J; Huang X; Kantarjian HM; Andreeff M; Ravandi F; Konopleva M
    Clin Cancer Res; 2017 Jul; 23(13):3385-3395. PubMed ID: 28096272
    [No Abstract]   [Full Text] [Related]  

  • 33. CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission.
    Xie LH; Biondo M; Busfield SJ; Arruda A; Yang X; Vairo G; Minden MD
    Blood Cancer J; 2017 Jun; 7(6):e567. PubMed ID: 28574487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic Significance of CD45
    Sun Q; Zhang HX; Hu CY; Han YH; Bu XT; Li HJ; Li ZY; Yan ZL; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):702-707. PubMed ID: 31204919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the alpha subunit of IL-3 receptor (CD123) in patients with acute leukemia.
    Aldoss I; Clark M; Song JY; Pullarkat V
    Hum Vaccin Immunother; 2020 Oct; 16(10):2341-2348. PubMed ID: 32692611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells.
    Wang M; Wu H; Duan M; Yang Y; Wang G; Che F; Liu B; He W; Li Q; Zhang L
    Life Sci; 2019 Sep; 232():116663. PubMed ID: 31323275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.
    Mi Y; Xue Y; Yu W; Liu S; Zhao Y; Meng Q; Bian S; Wang J
    Leuk Lymphoma; 2008 Mar; 49(3):524-30. PubMed ID: 18297530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
    Tavernier E; Le QH; Elhamri M; Thomas X
    Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auger electron radioimmunotherapeutic agent specific for the CD123+/CD131- phenotype of the leukemia stem cell population.
    Leyton JV; Hu M; Gao C; Turner PV; Dick JE; Minden M; Reilly RM
    J Nucl Med; 2011 Sep; 52(9):1465-73. PubMed ID: 21816968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia.
    Xu S; Zhang M; Fang X; Meng J; Xing H; Yan D; Liu J; Yang Y; Wen T; Zhang W; Wang J; Wang C; Xu H
    J Hematol Oncol; 2021 Nov; 14(1):193. PubMed ID: 34774070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.